Text Messaging Program Increased Smoking Cessation Rates at 6 ... The Cardiology Advisor
See more here:
Text Messaging Program Increased Smoking Cessation Rates at 6 ... - The Cardiology Advisor
Text Messaging Program Increased Smoking Cessation Rates at 6 ... The Cardiology Advisor
See more here:
Text Messaging Program Increased Smoking Cessation Rates at 6 ... - The Cardiology Advisor
Newswise LOS ANGELES (April 7, 2023) --Two Smidt Heart Institute experts have been honored for their contributions to medical research by being inducted into select medical societies, while a third expert has been selected for a leadership position.
Cardiologist, echocardiographer and clinician-scientistSusan Cheng, MD, director of Cardiovascular Population Sciences in theSmidt Heart Instituteand the Erika J. Glazer Chair in Womens Cardiovascular Health and Population Science, has been elected to the American Society for Clinical Investigation (ASCI) Council.ASCI is regarded as the most prestigious honorary society in internal medicine, andCheng is one of only two U.S. physicians elected to the council this year.
Cheng leads research programs aimed at uncovering drivers of cardiovascular aging in women and men, why the sexes experience the aging process differently, and how aging leads to different types of heart disease.
Im honored to serve the organization in this capacity, said Cheng, whose term begins April 21,andIm particularly eager to represent Cedars-Sinai on the council as well as to continue my work in the study of sex differences in cardiovascular pathophysiology and disease.
The society also inducted cardiac electrophysiologistEugenio Cingolani, MD, director of the Cardiogenetics Program at the Smidt Heart Institute, for outstanding achievement in academic medicine.
Cingolani, whose most recently published study explored how to create biological pacemakers by reprogramming heart cells to make them beat spontaneously, is among the societys 100 new active and international members from 49 institutions. Cingolani and his peers will be inducted into the society during a special ceremony Friday, April 21, in Chicago at a joint meeting with the Association of American Physicians and the American Physician Scientists Association.
The American Society for Clinical Investigation is a nonprofit medical honor society comprising more than 3,000 physician-scientists from all medical specialties. The society is dedicated to advancing research that extends understanding of diseases and improves treatment; members are committed to mentoring future generations of physician-scientists.
Founded in 1908, the organization is one of the nations oldest medical honor societies and is among the few focused on the special role of physician-scientists in research, clinical care and medical education, as well as leadership positions in academic medicine and the life sciences industry.
Improving heart health through novel research and treatment protocols is among my greatest passions, said Cingolani, also an associate professor of Cardiology and director of Preclinical Research at Smidt Heart Institute, and recognition for that from the ASCI is a career highlight.
Damini Dey, PhD, directorof the Quantitative Image Analysis Program in theBiomedical Imaging Research Instituteat Cedars-Sinai,has been inducted into the 2023 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellowsrecognition that is reserved for the top 2% of medical and biological engineers.
Dey, professor of Biomedical Sciences at Cedars-Sinai and co-associate director of the Biomedical Imaging Research Institute, wasnominated, reviewed and elected by peers and members of the AIMBE College of Fellows for her pioneering contributions in artificial intelligence analysis of cardiac images to predict and prevent heart attacks. Dey was formally inducted March 27 in Arlington, Virginia, as part of the groups annual meeting.
TheAmerican Institute for Medical and Biological EngineeringCollege of Fellows honors those who have made outstanding contributions to engineering and medicine research, practice or education and to the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.
What an incredible honor to receive this recognition, Dey said. Ive always been impressed by the mission of the organization, in particular its commitment to accelerating medical and biological innovation. I look forward to continuing my research emphasis on AI and machine learning in cardiac imaging to predict heart attack risk and to precisely quantify the effect of prevention strategies.
Dey is among 140 colleagues who make up the AIMBE College of Fellows Class of 2023. Inductees have previously included Nobel Prize laureates and Presidential Medal of Science and/or Technology and Innovation recipients.
My congratulations to Dr. Cheng, Dr. Cingolani and Dr. Dey on receiving such prestigious acknowledgement from two highly regarded organizations on their incredible clinical and research contributions to our understanding, diagnosis, treatment and prevention of cardiovascular diseases,saidJeffrey Golden, MD, vice dean of Research and Graduate Education and director of the Burns and Allen Research Institute at Cedars-Sinai.The recognition is admirable, as is their commitment to advancements in heart health.
The Smidt Heart Institute is ranked #1 in California and #3 in the nation for Cardiology & Heart Surgery inU.S. News & World Reports Best Hospitals 2022-23.
Read More On The Cedars-Sinai Blog:A New Partner In Heart Disease Prediction: AI
Excerpt from:
Cedars-Sinai Heart Experts Elected to Lead, Join Prominent Medical Societies - Newswise
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and the American College of Cardiology (ACC) today released the latest NCD Academy course, Health Equity and Social Determinants of Health in NCDs, coinciding with World Health Day and the theme Health for All. The NCD Academy is a user-friendly, interactive online platform developed by the ACC in partnership with the NCD Alliance and the World Heart Federation and sponsored by Viatris. The program is designed to equip primary healthcare professionals with educational resources and skills to enhance their ability to prevent and treat non-communicable diseases (NCDs). The NCD Academys overarching goal is aligned with the vision to make health for all a reality, by providing continued education for skilled health workers and supporting people-centered care.
Health equity, as described by the WHO Commission on Social Determinants of Health (CSDH), is the absence of inequalities in healthcare that are avoidable by reasonable means. The new Health Equity and Social Determinants of Health in NCDs course aims to educate and increase awareness of health inequities and provide support on how to address them to achieve equitable care for all. Course topics led by leading experts in global health equity include an overview of social determinants of health; a closer look at the impact of structural discrimination; and strategies for tackling disparities in vulnerable communities, as well as low- and middle-income countries.
Health equity and broadening access to healthcare is core to Viatris mission of empowering people worldwide to live healthier at every stage of life. We are proud to collaborate with our NCD Academy partners to support the launch of the new course on Health Equity, as part of our continuing efforts to deliver access to health education on a global level, said Lobna Salem, Head of Medical Affairs, Developed Markets. NCDs account for over 70% of deaths globally, many of which are preventable. Viatris is committed to helping to reduce this number, as demonstrated through one of our initial sustainability goals announced in our 2021 Sustainability Report: to impact 100 million patients via HCP education and outreach regarding prevention, diagnosis and treatment options for cardiovascular disease, diabetes, cancer and other important chronic conditions to improve outcomes through the NCD Academy by the end of 2025.
Launched in 2020, the NCD Academy features courses on nearly all aspects of NCDs, including cardiovascular disease and cancer. More recent courses also address mental health and advocacy and their respective roles in the NCD crisis, from which no country is immune. The new Health Equity course is being rolled out throughout the month of April, available at ACC.org/NCDAcademy.
Health equity is a critical global health issue that must be addressed if we are to truly stem the tide of NCDs, said Dipti Itchhaporia, MD, MACC, former ACC president and a past chair of the Colleges Health Equity Task Force. Transforming cardiovascular care and improving heart health for all needs to start with solving for health equity. The ACC is proud to partner with Viatris, WHF and NCD Alliance to drive awareness and action around this important topic. Together we are delivering global education that inspires global action and, while there is still much work to be done, it is exciting to see how far weve come to date.
For more information about the NCD Academy and to view available courses visit ACC.org/NCDAcademy.
About the NCD Academy
NCD Academy equips healthcare professionals, such as general practitioners, internists, nurses and community health workers, with high-quality continuing education availableanytime, anywhere, and free of chargeon fundamental skills to prevent, manage and mitigate today's leading causes of death and disability. Courses address non-communicable diseases (NCDs) through an intersectional lens given shared risk factors and the tendency of NCDs to coexist with one another, as well as with infectious diseases. Courses include eLearning that emulates the experience of intensive face-to-face training through interactive knowledge application and practice in the form of patient cases and games such as trivia. The Academy has hosted 44 trainings, equipping more than 70,000 health care professionals across ten countries with the latest science, technology, resources and tools to manage and prevent NCDs. The program has reached physicians and patients across many countries including Argentina, China, Colombia, Egypt, India, Iraq, Mexico, Peru, the Philippines, Saudi Arabia, Spain and the United States.
About the American College of Cardiology
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. Asthe preeminent source of professional medical education for the entire cardiovascular care team since 1949,ACCcredentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines.Through its world-renowned family ofJACCJournals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring aworld where science, knowledge and innovation optimize patient care and outcomes. Learn more at ACC.org or follow @ACCinTouch.
About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
Contacts:
ACC:Nicole Napolinnapoli@acc.org
Viatris:Media:+1.724.514.1968Communications@viatris.com
Matt KleinMatthew.Klein@viatris.com
Investors: +1.724.514.1813InvestorRelations@viatris.com
Bill SzablewskiWilliam.Szablewski@viatris.com
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
Excerpt from:
NCD Academy launches new Health Equity and Social ... - EurekAlert
April 03, 2023
3 min read
Disclosures: Fuchs reports no relevant financial disclosures. McDermott and Newby report receiving grants and funding from the British Heart Foundation. Please see the study for all other authors' relevant financial disclosures.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Back to Healio
Subclinical, obstructive coronary atherosclerosis was linked to a more than 8-fold elevated risk for myocardial infarction in asymptomatic adults aged 40 years or older, according to researchers.
Andreas Fuchs, MD, PhD, of the department of cardiology at Copenhagen University HospitalRigshospitalet, and colleagues wrote that coronary atherosclerosis can develop at an early age and remain latent in the body for many years.
Coronary atherosclerosis is the key pathobiological process that is responsible for the development of myocardial infarction, and together, these conditions define ischemic heart disease, the researchers wrote. Subclinical coronary atherosclerosis comes before ischemic heart disease, and can evolve at an early age, even years before the clinical disease develops.
For more than 50 years, obstructive coronary artery disease, defined as a luminal coronary stenosis of 50% or greater, has been considered a key feature of elevated risk, they wrote. In the past decades, however, the extent of atherosclerosis in the coronary tree as well as specific morphologic features of the atherosclerotic plaque have been acknowledged as important risk factors.
Fuchs and colleagues conducted a prospective observational cohort study to define characteristics of subclinical coronary atherosclerosis linked to the development of MI in 9,533 asymptomatic participants aged at least 40 years without CVD. Their findings were recently published in Annals of Internal Medicine.
We tested the hypothesis that characteristics of subclinical coronary atherosclerosis are associated with an increased risk for MI in asymptomatic persons without known ischemic heart disease, they wrote.
The researchers used coronary computed tomography angiography to assess subclinical coronary atherosclerosis. Coronary atherosclerosis was then characterized by extent and luminal obstruction (obstructive being defined as greater than 50% luminal stenosis).
Fuchs and colleagues found that just over half 54% of the participants did not have subclinical coronary atherosclerosis, and, of the 46% who did, 10% had obstructive disease. Additionally, of those diagnosed, the condition was found more frequently in men than women (61% vs. 36%).
The researchers noted that, in the median follow-up of 3.5 years, 71 participants had an MI and 193 died. MI risk was higher in those with obstructive (adjusted relative risk [aRR] = 9.19; 95% CI, 4.49-18.11) and extensive (aRR = 7.65; 95% CI, 3.53-16.57) disease and highest in those with both extensive and obstructive subclinical coronary atherosclerosis (aRR = 12.48; 95% CI, 5.50-28.12) or obstructive-nonextensive (aRR = 8.28; 95% CI, 3.75-18.32).
Obstructive subclinical coronary atherosclerosis was associated with a more than 8-fold increased risk for MI, and the risk for either death or MI was increased 2-fold in persons with extensive subclinical coronary atherosclerosis, they wrote.
Fuchs and colleagues also wrote that, regardless of degree of obstruction, the risk for the composite end point of death or MI was increased in those with extensive disease: obstructive-extensive (aRR = 3.15; 95% CI, 2.05-4.83) and nonobstructive-extensive (aRR = 2.7 95% CI, 1.72-4.25).
Identification of luminal obstructive or extensive subclinical coronary atherosclerosis, which we have shown are associated with high risk, provides potentially clinically relevant, incremental risk assessment in patients without suspected or known ischemic heart disease undergoing cardiac CT and/or electrocardiogram-gated chest CT for other clinical indications, they wrote.
In an accompanying editorial, Michael McDermott, MBChB, a cardiology research fellow at the University of Edinburgh, and David E. Newby, DM, PhD, British Heart Foundation Duke of Edinburgh Chair of Cardiology, wrote that this exceptional and important study now provides a benchmark against which to observe the contemporary natural history of coronary artery disease.
It also provides invaluable data about event rates and prevalence of asymptomatic coronary artery disease that will inform public health prevention strategies and ongoing clinical trials of targeting preventative therapies in persons screened for occult coronary artery disease, McDermott and Newby wrote.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Back to Healio
Read the original here:
Asymptomatic coronary atherosclerosis linked to 8-fold higher risk ... - Healio
Introduction
In the recent literature, cardiology based training in different procedures and techniques has been garnering a lot of attention.13 As of 2019 over 90,000 physicians specialize in cardiac-based procedures and interpretation in the United States. One such procedure is echocardiography, and physicians who specialize in interpreting them are called primary echocardiographers, which include cardiologists and radiologists.4 22,521 active physicians practice in the field of cardiology and 28,025 active physicians practicing in radiology.5 In comparison, there are only 1667 anesthesiologists who practice cardiac anesthesia as a subspecialty.6 Subspecialization in cardiac anesthesiology requires at least 4 years of training in an anesthesiology residency program and at least 1 year of a cardiac anesthesiology fellowship.716
During their residency and fellowship years, most anesthesiologists will be trained in the use of echocardiography. One such type of echocardiography is transthoracic echocardiogram (TTE), in which a handheld transducer is held outside the heart.17,18 Although other forms of echocardiograms exist, such as intracardiac echo and stress echo, a transesophageal echocardiogram is often the approach in the perioperative setting. Compared to TTE, a transesophageal echocardiogram can be more sensitive at identifying etiologies of an embolic stroke.1921 One study suggests that TEE may be more suitable than TTE for detecting infective endocarditis.22 Transesophageal echocardiograms can assess the hearts function and detect symptoms of atherosclerosis, cardiomyopathy, heart failure, and more.23,24 This is because an ultrasound probe is guided into the esophagus, providing a closer view of the heart.2530 Interpreting TEEs have a significant impact throughout perioperative care in order to make a proper diagnosis.31 Although cardiac anesthesiologists, cardiologists, and radiologists are all trained in interpreting transesophageal echocardiography, an overwhelming majority of perioperative TEEs are performed by cardiac anesthesiologists. A study by Poterack recognized that out of 98 institutions surveyed, 54% of them have anesthesiologists in charge of TEE interpretations.32 Therefore, it is of utmost importance that cardiac anesthesiologists are well-trained in these procedures.
TEE specifically has seen major growth in terms of technology, use, and indications since its introduction to the medical community nearly half a decade ago.33 These advancements include the increase in TEE use from 29% in 2009 to 45% in 2011, and upgrades in technology such as the 3-D TEE systems.34 3-D TEE imaging has been shown to improve detecting infective endocarditis in a study by Chahine et al.35 Additional advancements include continuous TEE monitoring, strain imaging, and diastolic function assessment.36 These advancements have also increased the complexity of the procedure itself. For this reason, diagnostic evaluation of the TEE exams may vary disparately depending on who delivers the procedure and the expertise of the examiner.37 Despite the active role that cardiac anesthesiologists have in the perioperative setting, there is limited literature on the assessment of their ability to interpret intraoperative TEE. Our paper conducts a systematic literature review to assess the effectiveness with which cardiac anesthesiologists interpret TEE examinations compared to primary echocardiographers, such as cardiologists and radiologists.
The PRISMA systematic review model was used to execute this study and identify relevant literature.38 A comprehensive search was used on the MED-LINE database (PubMed) to yield articles used for our study. Step 1 included using a broad keyword search using the phrases Cardiology Anesthesiology Echocardiogram and Echocardiography Anesthesiology to produce 1114 and 684 articles, respectively, dating from 1952 to 2022. The criteria for inclusion and exclusion are shown below in Figure 1 including but not limited to articles being written in the English language.
Figure 1 Study flow chart.
From the search, a total of 363 articles were included based on the relevance of the title (Figure 1, step 1), and duplicates were then removed (Figure 1, step 2). The remaining articles were then screened based on their abstract (Figure 1, step 3). The last step executed was reading the full article to determine which publications will be used in the study (Figure 1, step 4). This process yielded a combination of quantitative and qualitative information that amounted to a total of 9 relevant articles for our topic of interest. Three researchers carried out the procedures to obtain the final sample. The investigation team agreed on the final selection of the literature (Table 1).
Table 1 Publications Included in the Systematic Review
After assembly of the 9 articles, they were divided according to whether they contained quantitative or qualitative data. There were three quantitative data containing the accuracy of cardiac anesthesiologists TEE readings. Accuracy is defined as the degree to which cardiac anesthesiologists TEE interpretation agreed with that of primary echocardiographers. The quantitative studies examined different parameters as part of the TEE procedure and also used different methods to assess accuracy. Cohens kappa coefficient and high-fidelity videotape evaluation were the methods of analysis used to evaluate the accuracy of the interpretation of these parameters. The number of correctly interpreted TEEs and the total number of TEEs were obtained from each of the three quantitative studies. These numbers were then used to calculate the mean accuracy in the interpretation of all TEEs to represent the overall accuracy of cardiac anesthesiologists (Table 2).
Table 2 Results of Transesophageal Echocardiogram Results in Systematic Review
PRISMA systematic review yielded a total of 3 quantitative studies and 6 qualitative studies for a total of 9 relevant studies. The three quantitative studies contained comparisons between cardiac anesthesiologists and radiologists, cardiac anesthesiologists and cardiologists, and cardiologists and radiologists.
Mathew et al contained the concordance rate of TEE interpretations amongst cardiac anesthesiologists, cardiologists, and radiologists. In the study, radiologists interpreted the same number of TEEs as cardiac anesthesiologists. For this reason, we decided to compare anesthesiologists to radiologists in this study. They found that anesthesiologists with less than 5 years of experience underestimated left ventricular fractional area change (FAC). On the other hand, anesthesiologists with greater experience had higher levels of concordance with radiologists, particularly in the assessment of the aorta, right atrium, pulmonary vein flow, and transmitral flow. Furthermore, cardiac anesthesiologists correctly interpreted 83% of TEEs when compared specifically to radiologists. Out of 2464 TEE exams, this comes out to a total of 2045 correctly interpreted TEEs. Nevertheless, comparisons between anesthesiologists and cardiologists (80% concordance) and cardiologists and radiologists (82% concordance) were all similar.
The study by Mishra et al contained information regarding the concordance between online interpretation by cardiac anesthesiologists and offline analysis by cardiologists. This study specifically examined left ventricle regional wall motion, valve function, and left and right ventricle function. 3620 out of 4161 TEEs were correctly interpreted by the cardiac anesthesiologists, amounting to an accuracy rating of 87%. Although this study did not state the number of anesthesiologists involved, they examined 3217 TEEs in a group of patients who underwent coronary bypass graftings and 629 TEEs in a group of patients who underwent valve procedures, yielding a total of 3846 TEEs that were interpreted.
The final quantitative study by Miller et al compared the performance of anesthesiologists to an expert cardiologist in recording and interpreting TEEs. Parameters measured in this study included size of the heart chambers, FAC, and degree of stenosis or insufficiency of heart valves. They found that their cardiac anesthesiologists correctly interpreted 1242 out of 1572 TEEs, a 79% accuracy rating. As indicated in Table 2, these three studies totaled 8197 interpreted TEEs by cardiac anesthesiologists, 84% of which were correctly interpreted.
The American Society of Echocardiography suggests that non-cardiologists such as radiologists and cardiac anesthesiologists who provide optimal TEE services should ideally undergo 6 months of full-time training in an active echocardiography training institution.39 They recommend being involved in 300 total TEE exams and performing at least 150 of those exams, and 15 h of TEE within 3 years per Continuing Medical Education (CME) standards. Thus, all physicians who were not formally trained in TEE should adhere to these standards. It may also be advisable to consider facilitating close interactions between cardiac anesthesiologists and cardiologists or radiologist echocardiographers, at least in the initial training phases.40
In our study design, we chose to compare the evaluation of TEE studies between attending anesthesiologists to primary attending echocardiographers, either cardiologists or radiologists. A prospective observational cohort study was performed between 1993 and 1997 meant to evaluate TEE as a safe and reliable technique during cardiac surgery.41 3217 TEEs were administered to 944 patients who underwent coronary artery bypass grafting (CABG) procedures, and another 629 TEES to 142 patients who underwent heart valve procedures. The attending anesthesiologists who performed the TEE had a minimum hands-on experience of performing and interpreting 500 TEE studies each. Although the study did not disclose the number of anesthesiologists included in the study, they found that there was a rather high concordance between anesthesiologists and cardiologists (87%). This suggests that anesthesiologists can interpret and perform TEE studies in a manner comparable to that of cardiologists.
Another study was done at Duke University Medical Center that assessed the concordance of TEE interpretation in a continuous quality improvement (CQI) program.4 In this study, 10 cardiac anesthesiologists conducted a total of 154 TEE studies that included the estimation of FAC using Bland-Altman methods. Fractional area change is a measure of right ventricular systolic function. It is clinically significant because it can be used to measure any impairments to right ventricle function, such as after a pulmonary valve replacement.42 All 154 of the TEE studies were reviewed by radiologists, 50 of which were also reviewed by cardiologists. Cardiac anesthesiologists were found to underestimate the FAC when compared to radiologists, especially if the anesthesiologist had less than 5 years of TEE experience. Anesthesiologists with more experience, however, were found to have higher levels of concordance with the radiologists. Ultimately, the high levels of concordance of anesthesiologists to radiologists (83%) and cardiologists (80%) suggest that anesthesiologists are proficient in TEE interpretation.
A prospective study done at the Madigan Army Medical Center evaluated the ability of anesthesiologists to perform and interpret TEE after revisions were made to their examination protocol.43 Namely, these revisions entailed going from a standard 10 view TEE examination to a 12 view in which 8 were from the original and 4 assessed with color Doppler. Eight cardiac anesthesiologists performed 135 TEE examinations, which were then compared with a final expert evaluation by a cardiologist, yielding an accuracy of 79%. Although this is considerably lower than the other studies we analyzed, this is inclusive of TEE examinations with omitted diagnoses (blanks on evaluation sheets). If these TEE examinations had not been included in the study, the rate of correct interpretation would have been 94%.
It has been shown in a study done at Aarhus University Hospital that anesthesiologists are capable of providing valuable information in interpreting TEE.44 A TEE was successfully performed on 525 children undergoing cardiac surgery and according to the results, interpretations of TEE performed by anesthesiologists resulted in a total of 184 alterations to treatment in 143 patients. Additionally, anesthesiologists were able to add 37% of new information and add 8% of decisive information out of all the TEEs interpreted.
Although our study indicates how effective anesthesiologists can be in perioperative care, there have been multiple studies that have shown experience and training is still valuable in both carrying out the TEE procedure and interpreting the results. One study compared the length of time it takes to obtain a TEE exam and how accurate the interpretation was between certified anesthesiologists and anesthesiology residents.45 Attending physicians and residents were recruited from both the Vanderbilt School of Medicine and The Icahn School of Medicine at Mount Sinai for a total of 15 residents and 11 attending physicians. Participants were required to obtain 10 standard views using TEE. The certified anesthesiologists were able to interpret 5 out of 10 images better than the residents, whereas the remaining 5 views were comparable to the residents. Results also indicated that certified anesthesiologists were able to acquire TEE images more quickly, suggesting that experience is necessary to become a proficient echocardiographer.
A study done at Mahidol University concurred with this by showing improvement in acquiring TEE images as the procedure was performed more often.46 An additional study performed at The Icahn School of Medicine at Mount Sinai suggested that more experienced anesthesiologists were able to score higher on multiple-choice questions that involved TEEs.47 Evidently, experience in echocardiography improves both the theoretical knowledge and the practical application of the skills involved in TEE.
Limitations to our study include the circumstances of assessment in our quantitative studies. Specifically, comparisons were made between on-line assessments by anesthesiologists and off-line assessments of the primary echocardiographers. It is plausible that there could have been a higher level of agreement between the two groups if they interpreted TEEs under the same circumstances. For example, there may have been higher concordance if the anesthesiologists evaluated TEE results after operation. Another limitation to our study is that most of our quantitative data were published nearly 20 years ago. If these studies were to be done today, it may be the case that we would see higher concordance between cardiac anesthesiologists and primary echocardiographers, especially because of the guidelines that were established since then.39 Another notable limitation of this study is that there were variations in the gold standard for interpreting TEEs. Some studies used expert echocardiographers as the gold standard, while others relied on the degree to which there was consensus amongst attending echocardiographers.
A possible method of improving clinical evaluation is by refining current indications for the use of echocardiography. For example, echocardiography currently plays a major role in the diagnosis and management of infective endocarditis (IE) as part of Dukes criteria. However, many patients are initially misclassified even though IE is a life-threatening emergency.4850 This is partly because a negative echocardiogram does not rule out IE and a false-positive result is not unusual with these tests. The fault here is not so much in the conductor of the test, but the test itself. Therefore, in these cases, it may be worth considering other imaging techniques. An 18F-FDG PET/CT scan has instead shown promising results with these patients.5156
Based on the studies presented, it is clear that anesthesiologists have an important role in the perioperative stages of patient care by performing and interpreting transesophageal echocardiograms. With continuous quality improvement, cardiac anesthesiologists are shown to function at a level equivalent to that of primary echocardiographers. The implementation of software programs to routinely test physician TEE skills and the implementation of standardized AI interpretation as a possible gold standard are noteworthy considerations for future investigation.
The authors declare no competing interests in this work.
1. Zhitny V, Iftekhar N, Alexander L, Ahsan C. Cardiology fellow diagnostic accuracy and data interpretation outcomes: a review of the current literature. Vasc Health Risk Manag. 2020;16:429435. PMID: 33116553; PMCID: PMC7585513. doi:10.2147/VHRM.S266510
2. Kohan LC, Nagarajan V, Millard MA, Loguidice MJ, Fauber NM, Keeley EC. Impact of around-The-clock in-house cardiology fellow coverage on door-to-balloon time in an academic medical center. Vasc Health Risk Manag. 2017;13:139142. PMID: 28458558; PMCID: PMC5403126. doi:10.2147/VHRM.S132405
3. Spahillari A, McCormick I, Yang JX, Quinn GR, Manning WJ. On-call transthoracic echocardiographic interpretation by first year cardiology fellows: comparison with attending cardiologists. BMC Med Educ. 2019;19(1):213. PMID: 31200721; PMCID: PMC6567532. doi:10.1186/s12909-019-1634-7
4. Mathew JP, Fontes ML, Garwood S, et al. Transesophageal echocardiography interpretation: a comparative analysis between cardiac anesthesiologists and primary echocardiographers. Anesth Analg. 2002;94(2):302309. PMID: 11812688. doi:10.1097/00000539-200202000-00013
5. AAMC. Number of people per active physician by specialty; 2019. Available from: https://www.aamc.org/what-we-do/mission-areas/health-care/workforce-studies/interactive-data/number-people-active-physician-specialty-2019. Accessed: June 13, 2022.
6. Adult cardiac anesthesiology. Careers in medicine; 2022. Available from: https://www.aamc.org/cim/explore-options/specialty-profiles/adult-cardiac-anesthesiology?check_logged_in=1#workforce. Accessed June 19, 2022.
7. Massachusetts General Hospital. Guide to cardiac anesthesia; 2022. Available from: https://www.massgeneral.org/heart-center/treatments-and-services/cardiac-surgery/guide-to-cardiac-anesthesia#:~:text=A%20cardiac%20anesthesiologist%20is%20a,a%20cardiac%20anesthesia%20fellowship%20program. Accessed November 21, 2022.
8. Penn State College of Medicine Residencies and Fellowships. Cardiac anesthesia fellowship; 2022. Available from: https://residency.med.psu.edu/programs/cardiac-anesthesia-fellowship/. Accessed March 31, 2023.
9. Department of Anesthesiology. Cardiothoracic anesthesiology fellowship; 2022. Available from: https://anesthesiology.weill.cornell.edu/education/fellowships/cardiothoracic-anesthesiology. Accessed March 31, 2023.
10. Cardiothoracic Anesthesia Fellowship - Brigham and Womens Hospital. Adult cardiothoracic anesthesia fellowship; 2022. Available from: https://www.brighamandwomens.org/anesthesiology-and-pain-medicine/clinical-fellowships/cardiothoracic2/cardiothoracic-fellowship-landing#:~:text=The%20fellowship%20is%20either%2012,%2D%20to%2024%2Dmonth%20program. Accessed March 31, 2023.
11. Cardiothoracic Anesthesiology Fellowship. Anesthesiology; 2022. Available from: https://keck.usc.edu/anesthesiology/training-education/fellowship-programs/cardiothoracic-anesthesiology-fellowship. Accessed March 31, 2023.
12. Department of Anesthesiology, Perioperative and Pain Medicine. Adult cardiothoracic anesthesia; 2022. Available from: https://med.stanford.edu/anesthesia/education/fellowships/clinical-fellows/acta.html. Accessed March 31, 2023.
13. Wdelaney. Adult cardiothoracic anesthesiology fellowship. Medical School - University of Minnesota; 2018. Available from: https://med.umn.edu/anesthesiology/education-training/fellowship-programs/cardiothoracic-anesthesiology-fellowship. Accessed March 31, 2023.
14. Department of Anesthesia & Critical Care | The University of Chicago. Adult cardiothoracic fellowship; 2022. Available from: https://anesthesia.uchicago.edu/education/adult-cardiothoracic-fellowship. Accessed November 21, 2022.
15. Johns Hopkins Anesthesiology and Critical Care Medicine. Cardiac anesthesiology and interventional echocardiography fellowship; 2022. Available from: https://anesthesiology.hopkinsmedicine.org/accm-homepage/cardiac-anesthesia/cardiac-anesthesia-fellowship/. Accessed November 21, 2022.
16. Adult Cardiothoracic Anesthesiology (ACTA) Fellowship. Department of Anesthesiology and Perioperative Medicine. University of Pittsburgh; 2022. Available from: https://www.anesthesiology.pitt.edu/education/clinical-fellowships/adult-cardiothoracic-anesthesiology-acta-fellowship. Accessed November 21, 2022.
17. Stanford Health Care (SHC) - Stanford Medical Center. Types; 2020. Available from: https://stanfordhealthcare.org/medical-tests/e/echocardiogram/types.html. Accessed June 13, 2022.
18. Phoenix Heart Center. Echocardiograms: transthoracic (TTE) & Transesophageal (TEE); 2017. Available from: http://www.phoenixheartcenter.com/echocardiograms-tte-tee/. Accessed November 10, 2022.
19. de Bruijn SF, Agema WR, Lammers GJ, et al. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke. 2006;37(10):25312534. PMID: 16946152. doi:10.1161/01.STR.0000241064.46659.69
20. Thomsen J. To TTE or Tee? European Stroke Organisation; 2021. Available from: https://eso-stroke.org/to-tte-or-tee/#:~:text=TEE%20is%20considered%20more%20sensitive,visualization%20of%20left%20ventricular%20thrombus. Accessed October 24, 2022.
21. Kapral MK, Silver FL. Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. CMAJ. 1999;161(8):989996. PMID: 10551199; PMCID: PMC1230713.
22. Noor A, Suffoletto M. An echocardiogram battle: tte vs tee in the diagnosis of infective endocarditis; 2019. Available from: https://shmabstracts.org/abstract/an-echocardiogram-battle-tte-vs-tee-in-The-diagnosis-of-infective-endocarditis/. Accessed November 10, 2022.
23. Johns Hopkins Medicine. Transesophageal echocardiogram; 2021. Available from: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/transesophageal-echocardiogram. Accessed June 19, 2022.
24. UPMC. Echocardiography - purpose, types, and what to expect: UPMC in central PA. Available from: https://www.upmc.com/services/south-central-pa/heart-vascular/heart/diagnosis/screenings/echo. Accessed March 31, 2023.
25. Heart and Stroke Foundation of Canada. Transesophageal Echocardiogram (TEE); 2022. Available from: https://www.heartandstroke.ca/heart-disease/tests/transesophageal-echocardiogram-tee. Accessed June 19, 2022.
26. Stanford Health Care (SHC) - Stanford Medical Center. Transesophageal Echocardiogram (TEE); 2017. Available from: https://stanfordhealthcare.org/medical-tests/t/transesophageal-echocardiogram.html. Accessed June 19, 2022.
27. Transesophageal echocardiography (TEE); 2021. Available from: https://www.heart.org/en/health-topics/heart-attack/diagnosing-a-heart-attack/transesophageal-echocardiography-tee. Accessed November 10, 2022.
28. Memorial Sloan Kettering Cancer Center. About Your Transesophageal Echocardiogram (TEE). Available from: https://www.mskcc.org/cancer-care/patient-education/patient-guide-transesophageal-echocardiogram-tee. Accessed March 31, 2023.
29. Healthline, Healthline Media. Transesophageal Echocardiogram (TEE). Available from: https://www.healthline.com/health/tee-procedure#reasons. Accessed March 31, 2023.
30. Transthoracic Echocardiography (TTE) or Transesophageal. Available from: https://mountnittany.org/wellness-article/transthoracic-echocardiography-tte-or-transesophageal-echocardiography-tee-when-------your-child-needs. Accessed March 31, 2023.
31. American society of Anesthesiologist. Statement on transesophageal echocardiography; 2022. Available from: https://www.asahq.org/standards-and-guidelines/statement-on-transesophageal-echocardiography. Accessed June 19, 2022.
32. Poterack KA. Who uses transesophageal echocardiography in the operating room? Anesth Analg. 1995;80(3):454458. PMID: 7864407. doi:10.1097/00000539-199503000-00004
33. Peterson GE, Brickner ME, Reimold SC. Transesophageal echocardiography. Circulation. 2003;107(19):23982402. doi:10.1161/01.cir.0000071540.97144.89
34. DAIC. Advances in transesophageal echo. DAIC; 2021. Available from: https://www.dicardiology.com/article/advances-transesophageal-echo. Accessed June 13, 2022.
35. Chahine J, Montane B, Alzubi J, et al. Improved diagnostic performance of contemporary transesophageal echocardiography with three-dimensional imaging for infective endocarditis. Circulation. 2020;142(Suppl_3):A13434A13434. doi:10.1161/circ.142.suppl_3.13434
36. Maxwell C, Konoske R, Mark J. Emerging concepts in transesophageal echocardiography. F1000Res. 2016;5:F1000Faculty Rev340. PMID: 26998250; PMCID: PMC4792209. doi:10.12688/f1000research.7169.1
37. Fatima H, Sharkey A, Qureshi N, et al. Three-dimensional transesophageal echocardiography simulator: new learning tool for advanced imaging techniques. J Cardiothorac Vasc Anesth. 2022;36(7):20902097. PMID: 34275733. doi:10.1053/j.jvca.2021.05.050
38. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b2535
39. Hahn RT, Abraham T, Adams MS, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26(9):921964. PMID: 23998692. doi:10.1016/j.echo.2013.07.009
40. Rafferty T, LaMantia KR, Davis E, et al. Quality assurance for intraoperative transesophageal echocardiography monitoring: a report of 846 procedures. Anesth Analg. 1993;76(2):228232. PMID: 8424496. doi:10.1213/00000539-199302000-00005
41. Mishra M, Chauhan R, Sharma KK, et al. Real-time intraoperative transesophageal echocardiography--how useful? Experience of 5016 cases. J Cardiothorac Vasc Anesth. 1998;12(6):625632. PMID: 9854658. doi:10.1016/s1053-0770(98)90232-4
42. DiLorenzo MP, Bhatt SM, Mercer-Rosa L. How best to assess right ventricular function by echocardiography. Cardiol Young. 2015;25(8):14731481. doi:10.1017/S1047951115002255
43. Miller JP, Lambert AS, Shapiro WA, Russell IA, Schiller NB, Cahalan MK. The adequacy of basic intraoperative transesophageal echocardiography performed by experienced anesthesiologists. Anesth Analg. 2001;92(5):11031110. PMID: 11323329. doi:10.1097/00000539-200105000-00005
44. Sloth E, Pedersen J, Olsen KH, Wanscher M, Hansen OK, Srensen KE. Transoesophageal echocardiographic monitoring during paediatric cardiac surgery: obtainable information and feasibility in 532 children. Paediatr Anaesth. 2001;11(6):657662. PMID: 11696140. doi:10.1046/j.1460-9592.2001.00737.x
45. Bick JS, Jr DS, Kennedy JD, et al. Comparison of expert and novice performance of a simulated transesophageal echocardiography examination. Simul Healthc. 2013;8(5):329334. PMID: 24030477. doi:10.1097/SIH.0b013e31829068df
46. Sawasdiwipachai P, Thanasriphakdeekul S, Raksamani K, Vacharaksa K, Chaithiraphan V. Learning curve for the acquisition of 20 standard two-dimensional images in advanced perioperative transesophageal echocardiography: a prospective observational study. BMC Med Educ. 2022;22(1):412. PMID: 35637456; PMCID: PMC9153196. doi:10.1186/s12909-022-03280-3
47. Konstadt SN, Reich DL, Rafferty T. Validation of a test of competence in transesophageal echocardiography. J Cardiothorac Vasc Anesth. 1996;10(3):311313. PMID: 8725408. doi:10.1016/s1053-0770(96)80088-7
48. Sarrazin JF, Trottier M, Tessier M. Accuracy of PET/CT for detection of infective endocarditis: where are we now? J Nucl Cardiol. 2019;26(3):936938. PMID: 29143245. doi:10.1007/s12350-017-1126-2
49. Prendergast BD. Diagnostic criteria and problems in infective endocarditis. Heart. 2004;90(6):611613. PMID: 15145855; PMCID: PMC1768277. doi:10.1136/hrt.2003.029850
50. Pecoraro AJK, Herbst PG, Pienaar C, et al. Modified Duke/European Society of Cardiology 2015 clinical criteria for infective endocarditis: time for an update? Open Heart. 2022;9:e001856. doi:10.1136/openhrt-2021-001856
51. Mahmood M, Kendi AT, Ajmal S, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol. 2019;26(3):922935. PMID: 29086386. doi:10.1007/s12350-017-1092-8
52. Ten HD, Slart RHJA, Sinha B, Glaudemans AWJM, Budde RPJ. 18F-FDG PET/CT in infective endocarditis: indications and approaches for standardization. Curr Cardiol Rep. 2021;23(9):130. PMID: 34363148; PMCID: PMC8346431. doi:10.1007/s11886-021-01542-y
53. Rouzet F, Iung B, Duval X, et al. 18F-FDG PET/CT in infective endocarditis. J Am Coll Cardiol. 2019;74(8):10411043. doi:10.1016/j.jacc.2019.06.049
54. Swart LE, Gomes A, Scholtens AM, et al. Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography in prosthetic heart valve endocarditis. Circulation. 2018;138(14):14121427. PMID: 30018167. doi:10.1161/CIRCULATIONAHA.118.035032
55. Wang TKM, Snchez-Nadales A, Igbinomwanhia E, Cremer P, Griffin B, Xu B. Diagnosis of infective endocarditis by subtype using 18F-fluorodeoxyglucose positron emission tomography/computed tomography: a contemporary meta-analysis. Circ Cardiovasc Imaging. 2020;13(6):e010600. PMID: 32507019. doi:10.1161/CIRCIMAGING.120.010600
56. Orvin K, Goldberg E, Bernstine H, et al. The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis. Clin Microbiol Infect. 2015;21(1):6976. doi:10.1016/j.cmi.2014.08.012
See the rest here:
Interpretation Accuracy of Transesophageal Echocardiograms | VHRM - Dove Medical Press
Newswise Rockville, Md. (April 5, 2023)Reporters are invited to join a virtual press conference featuring high-impact research to be presented at the American Physiology Summit. The press conference will be held online 1:302:15 p.m. EDT (10:3011:15 a.m. PDT) on Tuesday, April 18, 2023 (register to attend).
The event offers a preview of findings being shared at the 2023 American Physiology Summit, the flagship meeting of the American Physiological Society, to be held April 2023, 2023, in Long Beach, California. Advanced registration is recommended for reporters who would like to join the virtual press conference, access embargoed press materials online or attend the Summit in person.
The press conference will feature presentations and a moderated Q&A with authors of three new studies:
Trying to Lower Blood Pressure? Evening Exercise Might Be Best
Leandro Brito, PhD, a postdoctoral fellow at the Oregon Health & Science University, will share new findings on why older people who exercise in the evening show greater improvements in blood pressure than those who exercise in the morning.
Staying Safe When Its Hot: Study Identifies Temperature-humidity Combinations that Stress the Heart
Rachel Cottle, a doctoral candidate at Pennsylvania State University, will present research on the temperature-humidity combinations that lead to cardiovascular strain. The findings can help inform safety guidelines and policies that protect people when temperatures rise.
Fat Isnt Necessarily Bad! Full-fat Yogurt Helps Lower Glucose Levels in People with Prediabetes
Contrary to the messages that the public often receives about dietary fat, weight gain and chronic disease, Victoria Taormina, a doctoral candidate at the University of Vermont, will share recent findings suggesting that full-fat dairy products may be beneficial to blood glucose and fat metabolism.
For more on the science behind the biggest issues impacting life and health today, explore the American Physiology Summit schedule at a glance, full program and game-changer sessions.
To register for a press pass, pleasevisit our Summit Newsroomand submit apress registration form.
Follow #APS2023 onFacebook,Twitter, YouTube and LinkedIn.
Physiology is a broad area of scientific inquiry that focuses on how molecules, cells, tissues and organs function in health and disease. The American Physiology Summit (APS2023) is an innovative event for scientific exchange and networking. Thousands of researchers, educators and students will come together to share the most recent advances and breakthroughs impacting the research community and the world around us. APS 2023 is the annual meeting of the American Physiological Society, whose mission is to advance scientific discovery, understand life and improve health.
See more here:
Announcing Virtual Press Conference for the American Physiology Summit - Newswise
Story Links CLEVELAND, Ohio-- Fourteen members of the Ohio indoor track and field team have been named to the 2022-23 Women's Indoor Track and Field Academic All-MAC Team, the Mid-American Conference announced.
The Academic All-MAC honor is for a student-athlete who has excelled in athletics and academics. To qualify, a student-athlete must have at least a 3.20 cumulative GPA and have participated in at least 50 percent of the contests for that particular sport.First-year students and any transfer in their first year of residence are not eligible for the award.
The following individuals represented Ohio on the 2022-23 Academic All-MAC Team:1. Alyssa Christian, Sr., Psychology/English, 3.9702. Emily McKenzie, Jr., Communication Sciences and Disorders, 3.9043. Madelyn Bartolone, 5th, Studio Art/Art Therapy, 3.8814. Avril Moyer, So., Chemistry/BioChem, 3.8805. Stephanie Pierce, 5th, Physical Therapy, 3.8536. Michaela Frey, So., Communication Studies, 3.7477. Autumn Mohan, 5th, Health and Physical Education, 3.7158. Kenna Loveless, Jr., Exercise Physiology, 3.7149. Kelsi Harris, So., Psychology, 3.68010. Sarah Liederbach, So., Chemical Engineering, 3.59811. Millie Ryan, So., Middle Childhood Language Arts/Math, 3.56512. Carina Weaver, Sr., Exercise Physiology, 3.56313. Bailey Roberts, R-Jr., Exercise Physiology/Pre-Physical Therapy, 3.51214. Theresa Hagey, So., Nursing, 3.325
#OUohyeah
View original post here:
14 Ohio Indoor Track and Field Members Named Academic All-MAC ... - Ohio University Athletics
Elena Nechaeva//Getty Images
Imagine a world in which women get to control whenor even ifthey go through menopause. This is the vision CEO Daisy Robinton, PhD, set forth when she cofounded Oviva Therapeutics, a company dedicated to answering the many unanswered questions in female physiology through innovative biomedical research and the development of therapeutics that will delay the decline of the ovaries.
Get a preview of Oprah Dailys interview with Robinton and watch the full video below.
Ovarian health is a fundamental pillar of our overall health and well-being. It really sustains us, and unfortunately, the ovaries age at an accelerated rate relative to the rest of the body.
As a woman approaches menopause, the number of eggs she has, a.k.a. her ovarian reserve, declines. And once this hits the low threshold, that is a trigger for menopause. When the ovaries stop functioning, women have increased risk of cardiovascular disease, osteoporosis, immune dysfunction, neurocognitive decline, problems with sleep, problems with sex.
So in supporting the function of the ovaries for a longer period of time, were hoping that were ultimately supporting the health of women for a longer period of time. In other words, if you can slow that decline, you could potentially forestall menopause or choose not to have it altogether.
Theres not a lot of resources for women to understand their own health, but also theres a lack of research in this space, a lack of understanding of female physiology thats been historic in biomedical research and clinical development. I was really shocked to discover how underrepresented female physiology was in not only biomedical research but also clinical development. It wasnt until 2016 that female animals were required to be included in NIH-funded studies, and it wasnt until the early nineties that female people were mandated to be included in clinical trials.
I think a big piece of it is being a woman of reproductive age, interested in having children and being curious about my own health, and then realizing through that discovery that there was a lot I didnt knowthat nobody knew because of the historic underrepresentation of female subjects in clinical studies.
I asked myself, what would we know about human biology if we had dedicated the same amount of attention to study female physiology as we have to male physiology? And how has this impacted us more broadly as a society?
Any content published by Oprah Daily is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. It should not be regarded as a substitute for professional guidance from your healthcare provider.
In a refreshingly candid conversation with Oprah Daily Insiders, Oprah, Maria Shriver, Drew Barrymore, and doctors Sharon Malone, Heather Hirsch, and Judith Joseph, we set the record straight on all things menopause. Become an Oprah Daily Insider now to get access to this conversation and the full The Life You Want Class library.
Read more:
Imagine a World Where You Control If and When You Go Through ... - Oprah Mag
Financing will further drive commercial scale for HeartFlows AI-enabled portfolio of precision heart care products
MOUNTAIN VIEW, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the close of a $215 million Series F funding round by its parent company HeartFlow Holding, Inc., led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management. This new funding will enable HeartFlow to meet the growing demand for its commercial products, support a robust body of growing clinical evidence and advance its comprehensive product portfolio to help physicians to diagnose coronary artery disease (CAD) and guide their treatment decisions.
The financing follows a period of remarkable growth for HeartFlow. Coronary computed tomography angiography (CCTA) and FFRCT have already been recognized by the recent ACC/AHA Chest Pain Guidelines, and HeartFlows FFRCT technology is covered by 100% of Medicare and over 98% of commercial payers. With the recent FDA clearance of new products, the company is the first and only company to provide non-invasive coronary artery anatomy (RoadMap analysis), physiology (HeartFlow FFRCT) and plaque information (Plaque analysis) based on CCTA. These products enable physicians to gain more understanding of a patients CAD and are the most comprehensive approach to predict risk of a heart attack.1
HeartFlow has built a strong intellectual property portfolio, brought to market the only combined anatomy, physiology and plaque analysis to help diagnose and treat heart disease, and is now in over 725 hospital systems worldwide with over 180,000 patients served to date, said John Farquhar, Chief Executive Officer of HeartFlow. "The oversubscription of our Series F funding round, particularly in the current market backdrop, is a strong validation of our technology, our team and the opportunity in front of us. We appreciate the support of our investors, both existing and new, who share HeartFlow's vision to build a new standard of care for people at risk of heart disease.
HeartFlow is a leader in precision heart care and its AI-enabled products promise to help physicians more effectively diagnose and treat heart disease, which continues to be the leading cause of death in the U.S., said Nicholas Downing, M.D., a Managing Director at Bain Capital Life Sciences. We look forward to supporting the companys commitment to improving cardiovascular care for patients as it heads into this exciting next chapter of growth.
The HeartFlow product pipeline is expected to continue to propel the companys position as a precision diagnostics leader. HeartFlows additional product launches will enable the company to further support physicians in their commitment to improve cardiovascular patient outcomes.
J.P. Morgan acted as sole placement agent to HeartFlow.
About HeartFlow
HeartFlow is the global leader in revolutionizing precision heart care, uniquely combining human ingenuity with advanced AI technology. Headquartered in Mountain View, California, our technology has been published in more than 500 peer-reviewed publications that showcase the value of anatomy, physiology and plaque. We began our journey to improve CAD diagnosis with FFRCT and have now expanded our product portfolio to include anatomic stenosis and plaque information. To date, clinicians have used our technology for over 180,000 patients to aid in the diagnosis of heart disease. For more information, visit http://www.heartflow.com and connect on Twitter and LinkedIn.
Contacts For Media
Linly KuHeartFlowmedia@heartflow.com
1 Emerald I - Lee, et al. JACC Imaging 2019.
Read more from the original source:
HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes ... - BioSpace
At the Washington University in St. Louis Board of Trustees meeting March 3, numerous faculty members were appointed with tenure, promoted with tenure or granted tenure. Their new roles will take effect July 1 unless otherwise indicated.
Sheldon A. Evans as professor of law at the School of Law; and
Benjamin Levin as professor of law at the School of Law.
Polina Lishko as professor of cell biology and physiology at the School of Medicine (effective March 3);
Hua Pan as associate professor of medicine at the School of Medicine (effective March 3);
Rene A. Shellhaas, MD, as professor of neurology at the School of Medicine (effective March 3); and
Aggie Toppins as associate professor of art at the Sam Fox School of Design & Visual Arts (effective March 3).
Ana M. Babus to associate professor of economics in Arts & Sciences;
Jonathan C. Barnes to associate professor of chemistry in Arts & Sciences;
Taylor Carlson to associate professor of political science in Arts & Sciences;
Joanna Dee Das to associate professor of dance in Arts & Sciences;
Bhupal Dev to associate professor of physics in Arts & Sciences;
Steven Frankel to associate professor of mathematics in Arts & Sciences;
Meghan Kirkwood to associate professor of art at the Sam Fox School;
Sebla B. Kutluay to associate professor of molecular microbiology at the School of Medicine (tenure effective March 3);
Calvin Lai to associate professor of psychological and brain sciences in Arts & Sciences;
SangMok Lee to associate professor of economics in Arts & Sciences;
Diana J. Montao to associate professor of history in Arts & Sciences;
Luis A. Salas to associate professor of classics in Arts & Sciences;
Yanli Song to associate professor of mathematics in Arts & Sciences;
Joshua A. Van Dyke-Blodgett to associate professor of biology in Arts & Sciences;
Kristin J. Van Engen to associate professor of psychological and brain sciences in Arts & Sciences;
Constance Vale to associate professor of architecture at the Sam Fox School; and
Kun Wang to associate professor of earth and planetary sciences in Arts & Sciences.
Link:
Board grants faculty appointments, promotions - The Source ... - Washington University in St. Louis